Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares Issued
Ratios

Collegium Pharmaceutical (COLL) EBIAT (2016 - 2025)

Historic EBIAT for Collegium Pharmaceutical (COLL) over the last 10 years, with Q3 2025 value amounting to $31.5 million.

  • Collegium Pharmaceutical's EBIAT rose 23751.47% to $31.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $58.4 million, marking a year-over-year decrease of 3403.28%. This contributed to the annual value of $69.2 million for FY2024, which is 4368.19% up from last year.
  • Latest data reveals that Collegium Pharmaceutical reported EBIAT of $31.5 million as of Q3 2025, which was up 23751.47% from $12.0 million recorded in Q2 2025.
  • Over the past 5 years, Collegium Pharmaceutical's EBIAT peaked at $72.8 million during Q2 2021, and registered a low of -$25.0 million during Q4 2021.
  • Moreover, its 5-year median value for EBIAT was $12.0 million (2025), whereas its average is $11.0 million.
  • Its EBIAT has fluctuated over the past 5 years, first plummeted by 45978.73% in 2021, then soared by 441509.85% in 2023.
  • Quarter analysis of 5 years shows Collegium Pharmaceutical's EBIAT stood at -$25.0 million in 2021, then soared by 71.24% to -$7.2 million in 2022, then skyrocketed by 543.67% to $31.9 million in 2023, then tumbled by 60.75% to $12.5 million in 2024, then surged by 151.33% to $31.5 million in 2025.
  • Its last three reported values are $31.5 million in Q3 2025, $12.0 million for Q2 2025, and $2.4 million during Q1 2025.